Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/17/2019
Xynomic Pharma Gains Phase III Trial Approval for Novel RCC Drug Combo...
3/17/2019
5 Key Elements of Chinese Biopharma's "Cambrian Explosion"
3/15/2019
NHSA Releases 2018 Healthcare Security Sector Development Statistical ...
3/15/2019
Recent Executive Moves
3/15/2019
China Approves New Law against Forced Tech Transfers
3/13/2019
A Merck Cancer Treatment Has a Big Opportunity in China, Analyst Says
3/13/2019
CASI Pharma Announces Exclusive Distribution Partner for Melphalan in ...
3/13/2019
HitGen and Sun Pharma Enter DNA-Encoded Library Based Innovative Drug ...
3/13/2019
NHSA Issues Action Plan for 2019 NRDL Revision
3/13/2019
Chongqing Approved to Set Up Destination Port for First-Time Import of...
3/12/2019
CDE Publicizes 8+3 More Drug Applications To Be Granted Priority Revie...
3/8/2019
China to Open More Vaccine Related Areas to Foreign Companies
3/8/2019
Booming Chinese Biotech Confronted by Sudden Investment Drop
3/8/2019
Spain's Grifols Acquires Stake in Shanghai RAAS for US$1.9B
3/7/2019
CASI Pharma Announces CTA Approval for MARQIBO
3/7/2019
Novo Nordisk Launches Innovation Platform INNOVO in China
3/6/2019
Ambrx and BeiGene Announce Global R&D Collaboration to Develop...
3/6/2019
China Withdraws Preliminary Approval Process at the Provincial Level f...
3/6/2019
WuXi STA and Ark Biosciences Sign CMC Development and Manufacturing Ag...
3/5/2019
Central Government Report Highlights Pharma-related Major Tasks in 201...
3/5/2019
NHSA Issues Complementary Measures for the 4+7 Trial
3/5/2019
Novartis Reports Positive Data from Chinese Trial of Cosentyx for Psor...
3/4/2019
NHSA Commissioner Reveal Plan to Revise NRDL in 2019 at the Two Sessio...
3/1/2019
Recent Executive Moves
3/1/2019
IQVIA/McKinsey: Generics Continue to Dominate Chinese Pharma Market
3/1/2019
CDE Solicits Comments on eCTD Technical and Validation Guidelines
3/1/2019
I-Mab Biopharma and BCT to Collaborate on Arginine Depletion Therapy a...
3/1/2019
Novo Nordisk Becomes First to Sign Bilateral APA with China
3/1/2019
Financial-related Company News in Brief 02/2019
2/28/2019
NHSA Holds Hearing of Pharmaceutical Industry Representatives
Page:
149
/
361
Total number of articles:
10826
:
[First]
[<<]
[147]
[148]
[149]
[150]
[151]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit